EHC - Encompass Health 2023 adjusted earnings per share estimate range below consensus

• Encompass Health after the closing bell on Tuesday offered 2023 guidance that included a diluted earnings per share range below consensus.
• The healthcare services company projects adjusted EPS from continuing operations $2.87 to $3.16 ($3.24 consensus).
• Its 2023 revenue estimate range of $4.68B to $4.76B is above the consensus of $4.66B.
• Encompass Health's Q4 2022 results beat on the bottom line .
• Revenue of ~$1.14B in Q4, a 9% year-over-year increase, was also a beat.
• Encompass Health ended 2022 with cash and cash equivalents of $21.8M compared to $49.4M at the end of 2021.
• Read why Seeking Alpha contributor Zach Bristow considers Encompass Health ( NYSE: EHC ) a buy .

For further details see: